Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Hypertension in China
Launched by CHINESE ACADEMY OF MEDICAL SCIENCES, FUWAI HOSPITAL · Jun 12, 2017
Trial Information
Current as of July 22, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Stable chronic obstructive pulmonary disease (COPD) patients
- Exclusion Criteria:
- • Patients with other serious respiratory diseases
- • Patients with pulmonary hypertension other than group 3
- • Patients with right heart hypertrophy or dysfunction not caused by chronic obstructive pulmonary diseases
- • Patients with limited life expectancy
- • Patients with history of tracheal intubation or stoke, acute coronary syndrome in 6 months
- • Psychopath or addict
About Chinese Academy Of Medical Sciences, Fuwai Hospital
The Chinese Academy of Medical Sciences (CAMS) Fuwai Hospital is a leading institution in cardiovascular research and healthcare in China, renowned for its commitment to advancing medical knowledge and improving patient care. As a major clinical trial sponsor, Fuwai Hospital focuses on innovative therapies and interventions, leveraging its extensive resources and expertise in cardiology and related fields. The institution fosters collaboration among multidisciplinary teams of researchers and healthcare professionals, aiming to translate scientific discoveries into clinical applications effectively. With a robust regulatory framework and a dedication to ethical research practices, CAMS Fuwai Hospital plays a pivotal role in addressing critical health challenges and enhancing the quality of life for patients both nationally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials